HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 105
- Value
- $65.5K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | $65.5K | <0.1% | −50−32.3% | Reduced | Holders |
| Q1 2026 | 155 | $119.8K | <0.1% | −15−8.8% | Reduced | Holders |
| Q4 2025 | 170 | $131.2K | <0.1% | −25−12.8% | Reduced | Holders |
| Q3 2025 | 195 | $109.6K | <0.1% | +45+30.0% | Added | Holders |
| Q2 2025 | 150 | $78.8K | <0.1% | +35+30.4% | Added | Holders |
| Q1 2025 | 115 | $72.9K | <0.1% | +100+666.7% | Added | Holders |
| Q4 2024 | 15 | $10.7K | <0.1% | −1−6.3% | Reduced | Holders |
| Q3 2024 | 16 | $16.8K | <0.1% | +15+1,500.0% | Added | Holders |
| Q2 2024 | 1 | $1.05K | <0.1% | +1 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −15−100.0% | Sold out | Holders |
| Q4 2023 | 15 | $13.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 15 | $12.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 15 | $10.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 15 | $12.3K | <0.1% | +15 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q2 2022 | 1 | $1.00K | <0.1% | +1 | New | Holders |